Rheumatoid arthritis: open trials in Netherlands

26 open trials have a site in Netherlands. Registry data; only the trial team decides who can take part.

NCT06916806
A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.
Trial Treatment · Phase 1 · AstraZeneca
Academisch Medisch Centrum, Amsterdam
Registry updated 2026-10-19
NCT07873931
A Study of BMS-986553 in Participants With Refractory Autoimmune Diseases
Trial Treatment · Phase 1 · Bristol-Myers Squibb
Amsterdam · Leiden
Registry updated 2026-10-14
2024-513537-21-02
[18F]PEG-folate PET-CT imaging for monitoring of therapy response in Rheumatoid Arthritis patients
Trial Treatment · Phase 2 · Amsterdam UMC Stichting
Amsterdam UMC Stichting, Amsterdam · Universitair Medisch Centrum Groningen, Groningen
Registry updated 2026-10-05
2025-524593-42-00
Tapering optimisation with placebo-based mechanisms in rheumatoid arthritis: the TOP-RA trial
Trial Treatment · Phase 4 · Universiteit Leiden
Medisch Spectrum Twente, Enschede · Dijklander Ziekenhuis, Hoorn Nh · Frisius MC, Leeuwarden · Universiteit Leiden, Leiden · Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC), Rotterdam · Haga Hospital, 's-Gravenhage · Stichting Viecuri Medisch Centrum voor Noord-Limburg, Venlo
Registry updated 2026-10-05
2025-524005-32-00
A study to assess the safety and efficacy of different doses of ELV001 to treat active rheumatoid arthritis in patients with an inadequate response to methotrexate and tumor necrosis factor inhibition (START SYNERGY)
Trial Treatment · Phase 2 · Elevara Medicines Limited
Amsterdam UMC Research B.V., Amsterdam · Maastricht University Medical Center, Maastricht · Maasstad Ziekenhuis Stichting, Rotterdam
Registry updated 2026-09-21
2024-511470-79-00
3TR-PARTNER-RA
Trial Treatment · Phase 4 · Queen Mary University Of London
Amsterdam UMC Stichting, Amsterdam
Registry updated 2026-09-09
NCT07802678
Discontinuation of Disease-modifying Anti-rheumatic Drugs (DMARDs) in Rheumatoid Arthritis Patients Also Using TNF Inhibitors
Trial Treatment · Phase 4 · Sint Maartenskliniek
Reade revalidatie & reumatologie centrum te Amsterdam, Amsterdam · Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC), Rotterdam · Elisabeth-Tweesteden Ziekenhuis, Tilburg · Sint Maartenskliniek Stichting, Ubbergen
Registry updated 2026-09-03
2025-523127-21-00
A Study to Evaluate Targeted Therapies for Patients with Rheumatoid Arthritis
Trial Treatment · Phase 1 · AbbVie Deutschland GmbH & Co. KG
Amsterdam UMC Research B.V., Amsterdam · Leids Universitair Medisch Centrum (LUMC), Leiden
Registry updated 2026-09-01
NCT06977724
A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions of ABBV-319 in Adult Participants With Systemic Lupus Erythematosus (SLE), Sjogren's Disease (SjD) and Rheumatoid Arthritis (RA)
Trial Treatment · Phase 1 · AbbVie
Amsterdam UMC Stichting, Amsterdam · Universitair Medisch Centrum Utrecht, Utrecht
Registry updated 2026-08-10
2022-502021-18-00
The 3TR Molecular Pathobiology-Driven Precision Therapy in RA (3TR Precis-The-RA) study
Trial Treatment · Phase 4 · Queen Mary University Of London
Amsterdam UMC, Amsterdam
Registry updated 2026-08-05
2024-514489-38-01
Imaging of inflamed arteries in giant cell arteritis and inflamed joints in rheumatoid arthritis with a PET/CT scan.
Trial Treatment · Phase 2 · Universitair Medisch Centrum Groningen
VUMC Stichting, Amsterdam · UMCG, Groningen
Registry updated 2026-08-05
NCT02469662
Clinical Outcomes Study of the Nexel Total Elbow
Trial Treatment · Zimmer Biomet
Amphia Ziekenhuis Breda, Breda
Registry updated 2026-07-09
2024-517547-31-00
A placebo-controlled, single-blind, phase I study in healthy volunteers and patients with Rheumatoid Arthritis with ABO21009
Trial Treatment · Phase 1 · Aboleris Holdco
Centre for Human Drug Research, Leiden
Registry updated 2026-06-15
2024-520196-27-00
A phase Ib, open-label, ascending dose study to assess safety, tolerability and pharmacokinetics of PIT565 in participants with rheumatoid arthritis (RA)
Trial Treatment · Phase 1 · Novartis Pharma AG
Centre for Human Drug Research, Leiden
Registry updated 2026-04-01
2023-507714-27-00
MethMax trial
Trial Treatment · Phase 4 · Medical University of Vienna
Academisch Ziekenhuis Leiden, Leiden
Registry updated 2026-02-02
NCT07160231
REDO-JAK: Dose Reduction of Janus Kinase Inhibitors in Patients With Inflammatory Rheumatic Diseases
Trial Treatment · Phase 4 · Sint Maartenskliniek
Reade revalidatie & reumatologie centrum te Amsterdam, Amsterdam · Medisch Spectrum Twente, Enschede · Ziekenhuis St Jansdal, Harderwijk · Maastricht University Medical Center, Maastricht · Radboud universitair medisch centrum Stichting, Nijmegen · Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC), Rotterdam · Maasstad Ziekenhuis Stichting, Rotterdam · Elisabeth-Tweesteden Ziekenhuis, Tilburg · Sint Maartenskliniek Stichting, Ubbergen · Bernhoven B.V., Uden · Isala Klinieken Stichting, Zwolle
Registry updated 2025-09-17
NCT03938701
Fluorescence Imaging of IBD and RA Using Adalimumab-800CW
Trial Treatment · Phase 2 · University Medical Center Groningen
University Medical Center Groningen, Groningen
Registry updated 2025-08-19
NCT04985435
Better After CHoosing. Randomly Allocated or Patient Preference Based Treatment With Filgotinib or TNFi in RA (BACH)
Trial Treatment · Phase 4 · R.Bos
Medical Center Leeuwarden MCL, Leeuwarden
Registry updated 2025-08-08
2024-515312-50-00
Investigating the (autoreactive) B cell compartment in antibody-mediated autoimmune diseases in comparison with the recall Tetanus Toxoid response
Trial Treatment · Phase 4 · Leids Universitair Medisch Centrum (LUMC)
Leids Universitair Medisch Centrum (LUMC), Leiden
Registry updated 2025-07-08
2024-517112-30-00
Filgotinib bridging in newly diagnosed rheumatoid arthritis patients (FAST RA trial); A pragmatic randomized controlled non-inferiority low intervention clinical trial
Trial Treatment · Phase 4 · Medisch Spectrum Twente
Medisch Spectrum Twente, Enschede
Registry updated 2025-01-16
2025-520513-30-00
Tocilizumab Dose Optimization in Rheumatoid Arthritis
Trial Treatment · Phase 4 · Reade revalidatie & reumatologie centrum te Amsterdam
Noordwest Ziekenhuisgroep Stichting, Alkmaar · Reade revalidatie & reumatologie centrum te Amsterdam, Amsterdam · Amsterdam UMC Stichting, Amsterdam · Maasstad Ziekenhuis Stichting, Rotterdam · Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC), Rotterdam · Sint Maartenskliniek Stichting, Ubbergen
Registry updated 2025-01-16
NCT05941559
EMDR for Persistent Pain in RA
Trial Treatment · Medisch Spectrum Twente
Medisch Spectrum Twente, Enschede
Registry updated 2024-11-29
2024-517865-17-01
Comparing the effectiveness of tofacitinib extended release (XR) chronotherapy, morning versus evening dosing, in rheumatoid arthritis (RA) and psoriatic arthritis (PsA) patients from a patient's, clinical as well as a translational point of view.
Trial Treatment · Phase 4 · Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
IJsselland Ziekenhuis, Capelle aan den IJssel · Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC), Rotterdam
Registry updated 2024-09-30
NCT05003310
ConsideRAte Study - Splenic Stimulation for RA
Trial Treatment · Galvani Bioelectronics
Academic Medical Center (AMC) Dept of Rheumatology & Clinical Immunology, Amsterdam · Maxima Medical Center, MMC, Eindhoven
Registry updated 2024-05-22
NCT04955899
Safety of Splenic Stimulation for RA
Trial Treatment · Galvani Bioelectronics
Academic Medical Center (AMC) Dept of Rheumatology & Clinical Immunology, Amsterdam
Registry updated 2024-02-14

All Rheumatoid arthritis trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error